RenovaCare, Inc. Appoints Ben Walthall to its Advisory Board
July 11, 2019 at 08:30 am
Share
RenovaCare, Inc. announced the appointment of Dr. Ben Walthall to the company’s Advisory Board. Dr. Walthall joins RenovaCare within weeks of the appointments of Dr. Rodney L. Sparks as Vice President of Intellectual Property and Dr. Roger Esteban-Vives to the position of Vice President of Research and Product Development. Among other duties, Dr. Walthall will provide ongoing support to Dr. Esteban-Vives in new product development and expanding the use of the RenovaCare technology platform for medical conditions beyond burns, such as reconstructive surgery and cosmetic applications, including acne scarring, wrinkles and tattoo removal. While at Johnson and Johnson, he also served as Worldwide Director R&D of Tissue Regeneration and previously as Worldwide Director R&D Advanced Wound Care.
RenovaCare, Inc. is a clinical-stage biotechnology company. The Company is focused on developing autologous (self-donated) stem cell therapies for the regeneration of human organs. The Company through its wholly owned subsidiary, RenovaCare Sciences Corp. is focusing on the research, development and commercialization of autologous (using a patientâs own cells) cellular therapies that can be used for medical and aesthetic applications. The Companyâs CellMist System is a cell isolation procedure that enzymatically renders stem cells from the patientâs own skin or other tissues. The resulting stem cell suspension is administered topically from the Companyâs novel solution sprayer device (the SkinGun) as a cell therapy for wounds including burns to facilitate healing. Its SkinGun spray device is an advanced technology, using a gentle positive-pressure air stream to spray the CellMist Solution onto wounds.
RENOVACARE, INC. 
